Cefpodoxime: Pharmacokinetics and therapeutic uses

Indian Journal of Pediatrics

Volumn 70, Issue 3, 2003, Pages 227-231

  Chugh, Krishan ^a   Agrawal, Shruti ^a  

^a SIR GANGA RAM HOSPITAL   (India)

Author keywords

Broad spectrum; Oral third generation cephalosporin; Safe; Short course

Indexed keywords

ANTACID AGENT; CEFPODOXIME; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; CHOLINERGIC RECEPTOR BLOCKING AGENT; HISTAMINE H2 RECEPTOR ANTAGONIST; PROBENECID; PROPENTHALINE; UNCLASSIFIED DRUG;

ABDOMINAL PAIN; AGRANULOCYTOSIS; ANOREXIA; ANTIBIOTIC THERAPY; ANXIETY; APLASTIC ANEMIA; BLEEDING; BLOOD TOXICITY; BODY FLUID; DIARRHEA; DOSE CALCULATION; DRUG ABSORPTION; DRUG ACTIVITY; DRUG EFFECT; DRUG MECHANISM; DRUG METABOLISM; DRUG SAFETY; FATIGUE; FEVER; FLATULENCE; GASTROINTESTINAL SYMPTOM; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE COCCI; HEADACHE; HUMAN; HYPERSENSITIVITY; HYPOTENSION; INSOMNIA; INTESTINE ABSORPTION; KIDNEY DISEASE; KIDNEY FUNCTION; LIVER INJURY; LOWER RESPIRATORY TRACT INFECTION; MALAISE; MINIMUM INHIBITORY CONCENTRATION; NAUSEA; OTITIS MEDIA; PRURITUS; PSEUDOMEMBRANOUS COLITIS; REVIEW; SALIVATION DISORDER; SEIZURE; SIDE EFFECT; SINUSITIS; SKIN INFECTION; SOFT TISSUE INFECTION; TASTE DISORDER; THORAX PAIN; THRUSH; UPPER RESPIRATORY TRACT INFECTION; URINARY TRACT INFECTION; VERTIGO; VOMITING;

EID: 0037989899     PISSN: 00195456     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02725589     Document Type: Review

References (17)

1. Litvak K et al. Drug information. AHFS 1998: 124-163.
2. Kumazawa J. Summary of clinical experience with Cefpodoxime Proxetil in adults in Japan. Drugs 1991; 42 (Suppl 3): 1-66.
3. Kearns GL, Abdel-Rahman SM, Jacobs RF, Wells TG, Borin MT. Cefpodoxime pharmacokinetics in children: effect of food. Pediatr Inf Dis J 1998; 17 (9): 799-804.
4. Borin MT. A review of the pharmacokinetics of Cefpodoxime Proxetil. Drugs 1991; 42(3): 13-21.
5. th edn. London, Churchill Livingstone, 1997.
6. Frampton JE, Brodgen RN, Langtry HD, Buckley MM. Cefpodoxime Proxetil: A review of its antibacterial activity, pharmacokinetic properties and therapeutic potential. Drugs 1992; 44 (5): 889-917.
7. Paulsen O. Cefpodoxime Proxetil- An oral cephalosporin with improved bacterial activity. Drugs of Today 1993; 29 (2): 133-153.
8. nd edn. UK, WB Saunders 1999; 1: C113-135.
9. Lezama MS. Comparison of cefpodoxime proxetil and amoxicillin/clavulanic acid in the treatment of elderly patients with acute exacerbation of chronic bronchitis and pneumonia. Current Therapeutic Research 1996; 57 (Suppl A): 97-102.
10. Fulton B, Perry CM. Cefpodoxime proxetil: a review of its use in management of bacterial infections in pediatric patients. Pediatric Drugs 2001; 3(2): 137-158.
11. Stevens DL, Pien F. Comparison of oral cefpodoxime proxetil and cefaclor in the treatment of skin and soft tissue infections. Diagn Microbiol Infect Dis 1993; 16: 123-129.
12. Novak E, Paxton LM, Tubbs LF, Keck CW, Yatsu J. Orally administered cefpodoxime proxetil for treatment of uncomplicated gonococcal uretheritis in males: a dose response study. Antimicrob Agents Chemother 1992; 36 (8): 1764-1765.
13. Tapsall JW, Philips EA. The sensitivity of 173 Sydney isolates of Neisseria Gonorrhoeae to cefpodoxime and other antibiotics used to treat gonorrhea. Pathology 1995; 27: 64-66.
14. Janknegt R, Vander Meer JW. Sequential therapy with intravenous and oral cephalosporins. J Antimicr Chemoth 1994; 33: 169-171.
15. Hendrickson JR, North DS. Pharmaeconomic benefit of antibiotic step-down therapy: Converting patients from intravenous ceftriaxone to oral cefpodoxime proxetil. Ann Pharmacother 1995; 29: 561-565.
16. nd edn. 1998; 2291-2294.
17. th edn. 1996, 1073-1102.